Corvus Pharmaceuticals Inc R&D Symposium Transcript
I think we should get started. We have a lot to cover today. We're really excited to be back in New York, able to meet all of you and to review all the programs at Corvus.
First of all, can everybody hear me? Good. I'm not going to use that podium because I don't know, it's kind of boring and I'm afraid I'll fall off of it. So I think that this enables me to move around and make some eye contact.
So my name is Richard Miller. I'm the CEO of Corvus Pharmaceuticals. And we have a really packed agenda today. So I would like to get started.
Next slide is our forward-looking statements, which you can review at your leisure. I'm very pleased today to be joined by 3 other speakers. I will be presiding at the meeting. But really, that's -- that's my pleasure to be associated with these 3 individuals. First, we have Dr. Neel Gupta, who's an oncologist from Stanford University. Neel is a clinical assistant professor and is an expert in lymphomas. We're also joined by Erik Verner. Dr.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |